Arabesque Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-5,279
Closed -$2.71M 47
2022
Q4
$2.71M Buy
5,279
+274
+5% +$139K 0.92% 40
2022
Q3
$2.27M Buy
5,005
+673
+16% +$322K 1.11% 28
2022
Q2
$2.09M Buy
4,332
+685
+19% +$339K 1.1% 26
2022
Q1
$1.79M Buy
+3,647
New +$1.67M 0.62% 87

Other funds holding ELV

Arabesque Asset Management's ELV Position: Q1 2023 in Review

Arabesque Asset Management sold out of Elevance Health (ELV) in Q1 2023, closing a stake of 5,279 shares — an estimated $2.71M sold.

Arabesque Asset Management first reported a position in ELV in Q1 2022 and held it in 4 quarters. The position peaked at $2.71M in Q4 2022. 1,516 funds tracked by Wall St. Rank hold ELV as of Q1 2023.

  • Arabesque Asset Management reported no remaining Elevance Health position as of Q1 2023 after selling out during the quarter.
  • Arabesque Asset Management sold 5,279 Elevance Health shares in Q1 2023, an estimated $2.71M.
  • Arabesque Asset Management first reported a position in Elevance Health in Q1 2022 and held it in 4 quarters.
  • Arabesque Asset Management's Elevance Health position peaked at $2.71M in Q4 2022.
  • 1,516 funds tracked by Wall St. Rank held Elevance Health as of Q1 2023.

Based on Arabesque Asset Management's 13F filing for Q1 2023.